Mast Therapeutics, Inc. (MSTX)

[lux1]

The lock up period after the merger should raise strongly the PPS. Savara current stakeholders and Mast managers can't sell the new shares for several months, I think that the amount of shares locked are about the 70-80% of the float.Very few shares could be traded after the merger and if all the good news about AIR, Savara drugs and Epic database will come out after the merger easily a x2 or x3 or much more.
IMO